LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 2543 | 2875 | 5557 | 0.5173 | 0.1148 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 2543 | 3526 | 5734 | 0.6149 | 0.3211 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 2543 | 3651 | 5761 | 0.6337 | 0.3586 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 2543 | 3551 | 5760 | 0.6164 | 0.3270 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 2543 | 1832 | 5258 | 0.3484 | -0.2688 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 2543 | 2035 | 5438 | 0.3742 | -0.1841 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 2543 | 1938 | 5557 | 0.3487 | -0.2142 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 2543 | 1822 | 5734 | 0.3177 | -0.2476 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 2543 | 1966 | 5761 | 0.3412 | -0.1961 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 2543 | 1788 | 5760 | 0.3104 | -0.2583 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 2543 | 1397 | 5258 | 0.2657 | -0.4355 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 2543 | 1325 | 5438 | 0.2437 | -0.4483 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 2543 | 1503 | 5557 | 0.2705 | -0.3728 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 2543 | 1755 | 5734 | 0.3060 | -0.2712 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 2543 | 1799 | 5761 | 0.3123 | -0.2544 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 2543 | 1899 | 5760 | 0.3296 | -0.2194 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 2543 | 1731 | 5258 | 0.3292 | -0.3073 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 2543 | 1457 | 5438 | 0.2679 | -0.3984 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 2543 | 1083 | 5557 | 0.1949 | -0.5310 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 2543 | 1349 | 5734 | 0.2352 | -0.4177 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 2543 | 1417 | 5761 | 0.2460 | -0.3910 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 2543 | 1379 | 5760 | 0.2394 | -0.4049 |
| SK-BR-3 | LJP6 | 1 | A03 | 72 | hr | 2543 | 4634 | 5258 | 0.8812 | 0.7726 | |||
| SK-BR-3 | LJP6 | 1 | A04 | 72 | hr | 2543 | 4610 | 5258 | 0.8766 | 0.7638 | |||
| SK-BR-3 | LJP6 | 1 | A05 | 72 | hr | 2543 | 4872 | 5258 | 0.9264 | 0.8594 |